To create a pilot study in order to evaluate the feasibility of a prospective case-control study of oral supplementation with fish oil (docosahexaenoic acid [DHA]; eicosapentaenoic acid [EPA]) in a population with age-related macular degeneration (AMD).
Methods
A homogeneous group of 38 patients with drusenoid pigment epithelial detachment in one eye (PED) without choroidal new vessels (CNV) was selected. A complete ophthalmologic examination, and a complete profile of fatty acids in serum (S) and in red blood cell membranes (RBCM), were recorded at day 0 and month 6. In group 1, 22 patients were orally supplemented with EPA (720 mg/day) and DHA (480 mg/day) during 6 months. In group 2, 16 patients were followed as controls. Nutritional recommendations on fish consumption were given to both groups.
Results
In group 1, after 6 months supplementation we observed a significant blood enrichment in EPA (EPA-S: 2.20 vs 0.79, p<0.0001 and EPA-RBCM: 2.24 vs 0.85, p<0.0001) and in DHA (DHA-S: 2.47 vs 1.56, p<0.0001 and DHA-RBCM: 6.47 vs 4.67, p<0.0001). No change was observed in group 2 despite nutritional recommendations. In this short follow-up, no evolution to CNV was noted in either of the two groups. Neither side effects nor dropouts were observed in either of the groups.
Conclusions
This study supports the feasibility of a long-term double-masked prospective case-control study in an AMD population in order to evaluate a potential benefit from oral supplementation with DHA.
DeAngelisM.M., LaneA.M., ShahC.P., OttJ., DryjaT.P., MillerJ.W.Extremely discordant sib-pair study design to determine risk factors for neovascular age-related macular degeneration. Arch Ophthalmol2004; 122: 575–80.
3.
SeddonJ.M., WillettW.C., SpeizerF.E., HankinsonS.E.A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA1996; 276: 1141–6.
4.
DelcourtC., DiazJ., Ponton-SanchezA., PapozL.Smoking and age-related macular degeneration: the POLA Study. Arch Ophthalmol1998; 116: 1031–5.
5.
MitchellP., WangJ.J., SmithW., LeederS.R.Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol2002; 120: 1357–63.
6.
The Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol1992; 110: 1701–8.
7.
SolbergY., RosnerM., BelkinM.The association between cigarette smoking and ocular diseases. Surv Ophthalmol1998; 4: 535–47.
VandenLangenbergG.M., Mares-PerlmanJ.A., KleinR., KleinB.E., BradyW.E., PaltaM.Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol1998; 148: 204–14.
10.
van LeeuwenR., BoekhoornS., VingerlingJ.R.Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA2005; 294: 3101–7.
11.
ChoE., SeddonJ.M., RosnerB., WillettW.C., HankinsonS.E.Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol2004; 122: 883–92.
12.
Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol2001; 119: 1417–36.
13.
SeddonJ.M., AjaniU.A., SperdutoR.D.Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA1994; 272: 1413–20.
14.
RicherS., StilesW., StatkuteL.Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry2004; 75: 216–30.
15.
DelcourtC., CarriereI., DelageM., Barberger-GateauP., SchalchW., POLA Study Group. Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study. Invest Ophthalmol Vis Sci2006; 47: 2329–35.
16.
SeddonJ.M., RosnerB., SperdutoR.D.Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol2001; 119: 1191–9.
17.
SmithW., MitchellP., LeederS.R.Dietary fat and fish intake and age-related maculopathy. Arch Ophthalmol2000; 118: 401–4.
18.
ChoE., WillettW.C., SpiegelmanD.Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr2001; 73: 209–18.
19.
SanGiovanniJ.P., ChewE.Y., ClemonsT.E.Age-Related Eye Disease Study Research Group. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol2007; 125: 671–9.
20.
SanGiovanniJ.P., ChewE.Y.The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res2005; 24: 87–138.
21.
NeuringerM., AndersonG., ConnorW.E.The essentiality of n-3 fatty acids for the development and function of the retina and brain. Annu Rev Nutr1988; 8: 517–54.
KotoT., NagaiN., MochimaruH.Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice. Invest Ophthalmol Vis Sci2007; 48: 4328–34.
25.
SouiedE.H., BenlianP., AmouyelP.The epsilon 4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol1998; 125: 353–9.
26.
HaddadS., ChenC.A., SantangeloS.L., SeddonJ.M.The genetics of age-related macular degeneration: a review of progress to date. Surv Ophthalmol2006; 51: 316–63.
27.
SimopoulosA.P.n-3 fatty acids and human health: defining strategies for public policy. Lipids2001; 36(suppl): S83–89.
DasU.Beneficial effect(s) of n-3 fatty acids in cardiovascular diseases: but, why and how?Prostaglandins Leukot Essent Fatty Acids2000; 63: 351–62.
30.
RotsteinN.P., PolitiL.E., GermanO.L., GirottiR.Protective effect of docosahexaenoic acid on oxidative stress-induced apoptosis of retina photoreceptors. Invest Ophthalmol Vis Sci2003; 44: 2252–9.
31.
SimopoulosA.P.Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr1991; 54: 438–63.
32.
RobinsonW.G., KuwabaraT., BieiriJ.G.The roles of vitamin E and unsaturated fatty acids in the visual process. Retina1982; 2: 263–81.
33.
BazanN.G.The metabolism of omega-3 polyunsaturated fatty acids in the eye: the possible role of docosahexaenoic acid and docosanoids in retinal physiology and ocular pathology. Prog Clin Biol Res1989; 312: 95–112.
34.
SeddonJ.M., AjaniU., SperdutoR.Dietary fat intake and age-related macular degeneration. Invest Ophthalmol Vis Sci1994; 35: 2003.
35.
MaruoT., IkebukuroN., KawanabeK., KubotaN.Changes in causes of visual handicaps in Tokyo. Jpn J Ophthalmol1991; 35: 268–72.
36.
YuzawaM., TamakoshiA., KawamuraT., OhnoY., UyamaM., HondaT.Report on the nationwide epidemiological survey of exudative age-related macular degeneration in Japan. Int Ophthalmol1997; 21: 1–3.
